CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0100 (-33.33%)
Aug 17, 2026, 3:30 PM EST
CV Sciences Revenue
CV Sciences had revenue of $2.99M in the quarter ending June 30, 2026, a decrease of -17.54%. This brings the company's revenue in the last twelve months to $12.74M, down -14.90% year-over-year. In the year 2025, CV Sciences had annual revenue of $13.79M, down -12.20%.
Revenue (ttm)
12.74M
Revenue Growth
-14.90%
P/S Ratio
0.32
Revenue / Employee
296.35K
Employees
44
Market Cap
4.03M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.79M | -1.92M | -12.20% |
| Dec 31, 2024 | 15.71M | -299.00K | -1.87% |
| Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
| Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
| Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trees | 14.50M |
| CordovaCann | 9.83M |
| Panacea Life Sciences Holdings | 2.76M |
| Rafarma Pharmaceuticals | 133.33K |
| Indo Global Exchange(s) PTE | 3.49K |
CV Sciences News
- 4 days ago - CV Sciences Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - CV Sciences Earnings release: Q2 2026 - Filings
- 4 days ago - CV Sciences Quarterly report: Q2 2026 - Filings
- 4 days ago - CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results - Accesswire
- 6 days ago - CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids - Accesswire
- 7 days ago - CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026 - Accesswire
- 7 weeks ago - CV Sciences Expands +PlusHLTH(TM) Portfolio with Personalized Wellness Solutions for Healthy Aging - Accesswire
- 3 months ago - CV Sciences Earnings Call Transcript: Q1 2026 - Transcripts